Teva Branded Pharmaceutical Products R&d Llc

This study aimed to test the safety and find the right dose of an experimental drug called TAK-573 when given with other standard medications to people with multiple myeloma that has returned or stopped responding to prior treatments. The trial was designed to enroll about 135 pa…

This study is testing whether two different doses of an experimental medication called TEV-48574 can help control symptoms of moderate to severe Crohn's disease or ulcerative colitis over the long term. The medication is given as an injection under the skin every four weeks. The …

This early-stage trial is testing the safety of an experimental medication called TEV-53408 for adults with vitiligo, a condition that causes loss of skin color. The study will involve 38 participants who will receive injections under the skin over 24 weeks, followed by a long mo…